The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,406.00
Bid: 2,404.00
Ask: 2,405.00
Change: 19.00 (0.80%)
Spread: 1.00 (0.042%)
Open: 2,397.00
High: 2,409.00
Low: 2,385.00
Prev. Close: 2,387.00
BATS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Closing of Notes Offering

24 Mar 2022 15:45

RNS Number : 9569F
British American Tobacco PLC
24 March 2022
 

 

 

24 March 2022

 

British American Tobacco Announces Closing of $200,000,000 Notes Offering

 

British American Tobacco p.l.c. ("BAT") announces that B.A.T Capital Corporation (the "Issuer"), a wholly owned subsidiary of BAT, has closed today an offering of $200,000,000 aggregate principal amount of 4.742% Notes due 2032 (the "Notes"). The Notes are part of the same series of notes as the $700,000,000 aggregate principal amount of the Issuer's 4.742% Notes due 2032 issued on March 16, 2022.

 

The Notes are fully and unconditionally guaranteed on a senior and unsecured and joint and several basis by BAT, B.A.T. International Finance p.l.c., B.A.T. Netherlands Finance B.V. and Reynolds American Inc. (collectively, the "Guarantors").

 

BAT intends to use the net proceeds of the offering of the Notes for general corporate purposes, including the potential repayment of upcoming maturities.

 

Citigroup Global Markets Inc. has acted as sole book-running manager for the offering.

 

The offering of the Notes has been made under BAT's existing effective shelf registration statement on file with the Securities and Exchange Commission (the "SEC"), which is available online at www.sec.gov. A final prospectus supplement and an accompanying prospectus describing the terms of the offering and other information relating to the Issuer and the Guarantors have been filed with the SEC. The shelf registration statement, the final prospectus supplement and the accompanying prospectus may be obtained, free of charge, by contacting Citigroup Global Markets Inc. toll-free at 1-800-831-9146.

 

The final prospectus supplement is also available at:

424B2 (sec.gov)

The shelf registration statement is also available at:

POSASR (sec.gov)

This communication shall not constitute an offer to sell nor a solicitation of an offer to buy the Notes. This offering is being made only pursuant to the Form F-3 registration statement, the prospectus supplement and the accompanying prospectus and only to such persons and in such jurisdictions as is permitted under applicable law.

 

 

A bout British American Tobacco p.l.c.

 

British American Tobacco is one of the world's leading consumer products businesses, with brands sold in more than 200 markets. We have strategic combustible and THP brands - Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Neo, Newport, Camel (in the U.S.) and Natural American Spirit (in the U.S.) - and over 200 brands in our portfolio, including a growing portfolio of potentially reduced-risk products. We hold robust market positions in each of our regions and have leadership positions in more than 55 markets.

 

 

 

Enquiries:

 

Investor Relations

British American Tobacco Investor Relations

Mike Nightingale / Victoria Buxton / William Houston / John Harney

+44 (0) 20 7845 1180 / 2012 / 1138 / 1263

 

 

British American Tobacco Press Office

+44 (0) 20 7845 2888 (24 hours) | @BATPlc

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEZLFLLXLBBBV
Date   Source Headline
8th May 202410:40 amRNSDirector/PDMR Shareholding
8th May 202410:35 amRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20241:05 pmRNSDirector/PDMR Shareholding
7th May 20241:00 pmRNSDirector/PDMR Shareholding
7th May 202411:20 amRNSDirector/PDMR Shareholding
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 202411:00 amRNSDirector/PDMR Shareholding
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20242:10 pmRNSDirector/PDMR Shareholding
2nd May 202412:00 pmRNSDirector/PDMR Shareholding
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20244:40 pmRNSTotal Voting Rights
1st May 20243:50 pmRNSCancellation of Treasury Shares
1st May 20247:05 amRNSTransaction in Own Shares
1st May 20247:00 amRNSShare Buyback – Non-Discretionary Agreement
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20245:42 pmRNSTender Offer Pricing
29th Apr 202412:40 pmRNSResult of Tender Offer
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20244:00 pmRNSResult of AGM
24th Apr 202411:45 amRNSAGM Statement
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 202410:10 amRNSDirector/PDMR Shareholding
17th Apr 202410:05 amRNSDirector/PDMR Shareholding
15th Apr 202411:55 amRNSTender Offer
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20246:00 pmRNSPublication of Final Terms
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 202411:10 amRNSPublication of Suppl.Prospcts
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20244:00 pmRNSDirector/PDMR Shareholding
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20242:10 pmRNSDirector/PDMR Shareholding
5th Apr 20242:05 pmRNSDirector/PDMR Shareholding
5th Apr 20242:00 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20243:30 pmRNSDirector/PDMR Shareholding
4th Apr 20242:40 pmRNSDirector Declaration
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20242:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.